November 8th 2024
The companies will work to create climate-friendly pMDIs using Orbia’s low global warming potential propellant.
November 2nd 2023
A novel approach for safety assessments in inhalation drugs may avoid animal testing for drug products.
March 17th 2023
Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.
April 5th 2022
Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.
February 1st 2022
CDMOs offer expertise and capacity for spray drying.